Citation Impact
Citing Papers
Effectiveness and Safety of Tenofovir Gel, an Antiretroviral Microbicide, for the Prevention of HIV Infection in Women
2010 StandoutScience
Comprehensive Assessment of HIV Target Cells in the Distal Human Gut Suggests Increasing HIV Susceptibility Toward the Anus
2013
Response definition criteria for ELISPOT assays revisited
2010
Combination of CTLA-4 and PD-1 blockers for treatment of cancer
2019
Administration of nucleoside-modified mRNA encoding broadly neutralizing antibody protects humanized mice from HIV-1 challenge
2017 StandoutNobel
Re-epithelialization and immune cell behaviour in an ex vivo human skin model
2020 Standout
Results and harmonization guidelines from two large-scale international Elispot proficiency panels conducted by the Cancer Vaccine Consortium (CVC/SVI)
2007
A phase 1, randomized, placebo-controlled study to evaluate the safety and immunogenicity of an mRNA-based RSV prefusion F protein vaccine in healthy younger and older adults
2020
Dendritic cells in cancer immunology and immunotherapy
2019 Standout
HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case–cohort analysis
2008
Vector-Mediated Antibody Gene Transfer for Infectious Diseases
2015
A novel role for neutrophils in IgE-mediated allergy: Evidence for antigen presentation in late-phase reactions
2018
The quest for a T cell-based immune correlate of protection against HIV: a story of trials and errors
2010
Targeting early infection to prevent HIV-1 mucosal transmission
2010 Nature
mRNA vaccines — a new era in vaccinology
2018 StandoutNobel
Improving the reach of vaccines to low-resource regions, with a needle-free vaccine delivery device and long-term thermostabilization
2011
The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy
2019 Standout
Coinfection With HIV-1 and HCV—A One-Two Punch
2009
Clinical Assessment of a Novel Recombinant Simian Adenovirus ChAdOx1 as a Vectored Vaccine Expressing Conserved Influenza A Antigens
2013
Periluminal Distribution of HIV-Binding Target Cells and Gp340 in the Oral, Cervical and Sigmoid/Rectal Mucosae: A Mapping Study
2015 StandoutNobel
Weighing the gold in the gold standard: challenges in HIV prevention research
2010
The Spectrum of Engagement in HIV Care and its Relevance to Test-and-Treat Strategies for Prevention of HIV Infection
2011 Standout
Superior immunogenicity of HCV envelope glycoproteins when adjuvanted with cyclic-di-AMP, a STING activator or archaeosomes
2017 StandoutNobel
Cancer immunotherapy via dendritic cells
2012 Standout
Successes and challenges of HIV prevention in men who have sex with men
2012
A Humanized Mouse Model to Study Hepatitis C Virus Infection, Immune Response, and Liver Disease
2011 StandoutNobel
Hepatocellular carcinoma
2021 Standout
Strong and persistent CD4+ T-cell response in healthy adults immunized with a candidate HIV-1 vaccine containing gp120, Nef and Tat antigens formulated in three Adjuvant Systems
2010
Development of an AS04-Adjuvanted HPV Vaccine with the Adjuvant System Approach
2011
Immunogenicity of therapeutic proteins: Influence of aggregation
2013
Life’s Essential 8: Updating and Enhancing the American Heart Association’s Construct of Cardiovascular Health: A Presidential Advisory From the American Heart Association
2022 Standout
In situ immune response and mechanisms of cell damage in central nervous system of fatal cases microcephaly by Zika virus
2018 Standout
mRNA vaccines for infectious diseases: principles, delivery and clinical translation
2021 StandoutNobel
Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study
2020 Standout
A Multi-Targeting, Nucleoside-Modified mRNA Influenza Virus Vaccine Provides Broad Protection in Mice
2020 StandoutNobel
Delivery technologies for cancer immunotherapy
2019 Standout
Efficacy of an Adjuvanted Herpes Zoster Subunit Vaccine in Older Adults
2015 Standout
Sources of diversity in T cell epitope discovery
2011
Exploring in vitro expression and immune potency in mice using mRNA encoding the Plasmodium falciparum malaria antigen, CelTOS
2022 StandoutNobel
Frameshift events predict anti–PD-1/L1 response in head and neck cancer
2018
Replicating and non-replicating viral vectors for vaccine development
2007
Promise and problems associated with the use of recombinant AAV for the delivery of anti-HIV antibodies
2016
Measuring human T cell responses in blood and gut samples using qualified methods suitable for evaluation of HIV vaccine candidates in clinical trials
2011
Aptamers as targeted therapeutics: current potential and challenges
2016 Standout
Novel cancer immunotherapy agents with survival benefit: recent successes and next steps
2011 StandoutNobel
Vector-mediated gene transfer engenders long-lived neutralizing activity and protection against SIV infection in monkeys
2009
Evaluation of yellow fever virus 17D strain as a new vector for HIV-1 vaccine development
2010 StandoutNobel
Circumcision status and HIV infection among MSM: reanalysis of a Phase III HIV vaccine clinical trial
2010
Microbicides and HIV prevention: lessons from the past, looking to the future
2009
Adeno-associated virus vector as a platform for gene therapy delivery
2019 Standout
Pre-erythrocytic malaria vaccines: identifying the targets
2012
Global epidemiology of HIV infection in men who have sex with men
2012 Standout
Selectively willing and conditionally able: HIV vaccine trial participation among women at “high risk” of HIV infection
2011
Increased surface expression of HIV-1 envelope is associated with improved antibody response in vaccinia prime/protein boost immunization
2017 StandoutNobel
Addressing Research Priorities for Prevention of HIV Infection in the United States
2010
Computational Design of Epitope-Scaffolds Allows Induction of Antibodies Specific for a Poorly Immunogenic HIV Vaccine Epitope
2010 StandoutNobel
Neutralizing antibodies generated during natural HIV-1 infection: good news for an HIV-1 vaccine?
2009
Microneedles for drug and vaccine delivery
2012 Standout
AAV Vectors Vaccines Against Infectious Diseases
2014
Heterologous Epitope-Scaffold Prime∶Boosting Immuno-Focuses B Cell Responses to the HIV-1 gp41 2F5 Neutralization Determinant
2011 StandoutNobel
Development of tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinic
2018 Standout
A Chimeric HIV-1 Envelope Glycoprotein Trimer with an Embedded Granulocyte-Macrophage Colony-stimulating Factor (GM-CSF) Domain Induces Enhanced Antibody and T Cell Responses
2011
Immunogenicity of protein therapeutics
2007
Improved DNA vaccination by skin-targeted delivery using dry-coated densely-packed microprojection arrays
2010
Exosomes in human semen carry a distinctive repertoire of small non-coding RNAs with potential regulatory functions
2014
HIV-1 Neutralization Profile and Plant-Based Recombinant Expression of Actinohivin, an Env Glycan-Specific Lectin Devoid of T-Cell Mitogenic Activity
2010 StandoutNobel
Genetic heterologous prime–boost vaccination strategies for improved systemic and mucosal immunity
2009
Prime–boost immunization with poxvirus or adenovirus vectors as a strategy to develop a protective vaccine for HIV-1
2010
Control of adaptive immunity by the innate immune system
2015 Standout
Photodynamic therapy – mechanisms, photosensitizers and combinations
2018 Standout
Development of Virus-Like Particle Technology from Small Highly Symmetric to Large Complex Virus-Like Particle Structures
2013 Standout
Strong Hearts, Healthy Communities: A Community‐Based Randomized Trial for Rural Women
2018
Newcastle Disease Virus Expressing a Dendritic Cell-Targeted HIV Gag Protein Induces a Potent Gag-Specific Immune Response in Mice
2010 StandoutNobel
Immunization with HIV Gag targeted to dendritic cells followed by recombinant New York vaccinia virus induces robust T-cell immunity in nonhuman primates
2011 StandoutNobel
Computation-Guided Backbone Grafting of a Discontinuous Motif onto a Protein Scaffold
2011 StandoutScienceNobel
Head and Neck Cancer
2020 Standout
Natural Products as Sources of New Drugs over the Nearly Four Decades from 01/1981 to 09/2019
2020 Standout
Recombinant Yellow Fever Vaccine Virus 17D Expressing Simian Immunodeficiency Virus SIVmac239 Gag Induces SIV-Specific CD8 + T-Cell Responses in Rhesus Macaques
2010
Human Immunodeficiency Virus Type 1 Subtype Distribution in the Worldwide Epidemic: Pathogenetic and Therapeutic Implications
2007
HIV-1 Vaccine Development After STEP
2010
Molecular Determinants of T Cell Epitope Recognition to the Common Timothy Grass Allergen
2010
The oral mucosa immune environment and oral transmission of HIV /SIV
2013
The biology , function , and biomedical applications of exosomes
2020 StandoutScience
Tissue‐resident memory T cells
2013
DNA vaccines: an historical perspective and view to the future
2010
Male circumcision for prevention of heterosexual acquisition of HIV in men
2009 Standout
A Systematic Review of Barriers and Facilitators to Minority Research Participation Among African Americans, Latinos, Asian Americans, and Pacific Islanders
2013 Standout
Viral Vectors for Gene Therapy: Translational and Clinical Outlook
2015
Outbreak analytics: a developing data science for informing the response to emerging pathogens
2019
Detection of T cell responses to a ubiquitous cellular protein in autoimmune disease
2014 StandoutScienceNobel
Biogenesis, Secretion, and Intercellular Interactions of Exosomes and Other Extracellular Vesicles
2014 Standout
CD40‐targeted adenoviral cancer vaccines: the long and winding road to the clinic
2012
Targeted gene knock-in by homology-directed genome editing using Cas9 ribonucleoprotein and AAV donor delivery
2017 StandoutNobel
Structural basis for Zika envelope domain III recognition by a germline version of a recurrent neutralizing antibody
2020 StandoutNobel
Rational Design of Doravirine: From Bench to Patients
2019
Early identification of antigen-specific immune responses in vivo by [ 18 F]-labeled 3′-fluoro-3′-deoxy-thymidine ([ 18 F]FLT) PET imaging
2011
Progress toward active or passive HIV-1 vaccination
2016
RosettaRemodel: A Generalized Framework for Flexible Backbone Protein Design
2011 StandoutNobel
Recombinant immunotoxin for cancer treatment with low immunogenicity by identification and silencing of human T-cell epitopes
2014 StandoutNobel
Works of Robin Mogg being referenced
Enhanced Rates and Magnitude of Immune Responses Detected against an HIV Vaccine: Effect of Using an Optimized Process for Isolating PBMC
2007
A Comparison of Standard Immunogenicity Assays for Monitoring HIV Type 1 gag-Specific T Cell Responses in Ad5 HIV Type 1 gag Vaccinated Human Subjects
2006
Tolerability of Two Sequential Electroporation Treatments Using MedPulser DNA Delivery System (DDS) in Healthy Adults
2009
The nasal mucosal late allergic reaction to grass pollen involves type 2 inflammation (IL-5 and IL-13), the inflammasome (IL-1β), and complement
2016
Pembrolizumab in patients with thymic carcinoma: a single-arm, single-centre, phase 2 study
2018
Real-time dynamic modelling for the design of a cluster-randomized phase 3 Ebola vaccine trial in Sierra Leone
2016
Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial
2008 Standout
Should baseline be a covariate or dependent variable in analyses of change from baseline in clinical trials?
2009
Cross-Clade Reactivity of HIV-1-Specific T-cell Responses in HIV-1-Infected Individuals From Botswana and Cameroon
2006
Mutational load (ML) and T-cell-inflamed microenvironment as predictors of response to pembrolizumab.
2017
Abstract LB-339: Biomarkers predictive of response to pembrolizumab in head and neck cancer (HNSCC)
2018
Detection of HIV Vaccine-Induced Cell-Mediated Immunity in HIV-Seronegative Clinical Trial Participants Using an Optimized and Validated Enzyme-Linked Immunospot Assay
2007
Efavirenz modulation of sleep spindles and sleep spectral profile
2014
Genomic determinants of response to pembrolizumab in head and neck squamous cell carcinoma (HNSCC).
2017